Before you applaud my transparency, know this: I didnt share because Im a noble person
Experimental models suggest that GLP-1 receptor activation may modulate the hypothalamicpituitarygonadal axis by influencing GnRH activity and gonadotropin release
The net effect of Akt activation is a shift toward anabolism: more protein synthesis and less protein breakdown
For individuals with diabetes and overweight or obesity, the ADA recommends as preferred pharmacotherapy a GLP-1 receptor agonist or a dual GLP-1/GIP receptor agonist with substantial weight-loss efficacy, meaning semaglutide or tirzepatide
Start your intake FDA Age Approval Status and Clinical Evidence in Youth Populations Semaglutide's pediatric approval (age 12+) emerged from the STEP TEENS trial, which demonstrated meaningful weight reduction in adolescents with obesity and comorbidities like type 2 diabetes
Learn to screen for contraindications (history of medullary thyroid cancer, multiple endocrine neoplasia, severe gastroparesis, etc.)